US M&A and equity raisings
3,392 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds
Deals dated after 30 September 2026 are still being collected.
445 deals · US$333bndisclosed · Healthcare · Clear
Columns
| Date | Target | Vendor | Acquirer | Type | Status | Value US$m | Sector | Advisers |
|---|---|---|---|---|---|---|---|---|
| Jul 2026 | Avere Therapeutics | – | Hansoh Pharmaceutical Group Co. | Stake | Announced | – | Biotech+2 | Goodwin (buy-side) |
| Jul 2026 | AdaptHealth Diabetes Health business | AdaptHealth Corp. | Cardinal Health | Asset sale | Announced | 235.0 | Healthcare Services+1 | Deutsche Bank (sell-side)Reed Smith (sell-side)J.P. Morgan (buy-side)Skadden, Arps, Slate, Meagher & Flom (buy-side)DLA Piper (buy-side) |
| Jul 2026 | Strive Medical | – | Cardinal Health | Acquisition | Announced | – | Healthcare Services+2 | J.P. Morgan (buy-side)BakerHostetler (buy-side)DLA Piper (buy-side) |
| Jul 2026 | Personalis | – | Tempus AI | Acquisition | Announced | 1,900.0 | Diagnostics+2 | Centerview Partners (sell-side)TD Securities (sell-side)Cooley (sell-side)Morgan Stanley (buy-side)Latham & Watkins (buy-side) |
| Jul 2026 | AtaiBeckley | – | Eli Lilly and Company | Acquisition | Announced | 2,800.0 | Biotech+2 | Moelis & Company (sell-side)Centerview Partners (sell-side)Latham & Watkins (sell-side)Citi (sell-side)Cooley (sell-side)Sullivan & Cromwell (sell-side)Goldman Sachs (buy-side)Ropes & Gray (buy-side) |
| Jul 2026 | Kira Pharmaceuticals | – | Jasper Therapeutics | Acquisition | Completed | – | Biotech+1 | Piper Sandler (sell-side)DLA Piper (sell-side)H.C. Wainwright & Co. (buy-side)Paul Hastings (buy-side) |
| Jul 2026 | Cynergy Rehab Group and Arkids Pediatric Day Centers | – | Pediatrics Plus | Acquisition | Completed | – | Healthcare Services | Stephens |
| Jul 2026 | Med Water Systems | – | AmeriWater | Acquisition | Completed | – | Water+2 | BofA Securities (sell-side) |
| Jul 2026 | Senti Holdings, Inc. (Midco) | Senti Biosciences Holdings | Celadon Partners SPV 35 | Acquisition | Announced | – | Biotech+2 | Lincoln International (sell-side)Gunderson Dettmer (sell-side)McDermott Will & Schulte (buy-side) |
| Jul 2026 | MAK-SYSTEM | The Carlyle Group | InVita Healthcare Technologies | Acquisition | Completed | – | Healthcare Software+1 | Willkie Farr & Gallagher (buy-side) |
| Jul 2026 | Avere Therapeutics | – | NextCure | Merger | Announced | – | Biotech+1 | Sullivan & CromwellSidley Austin (buy-side)Gibson Dunn (sell-side)Wedbush Securities (sell-side)Tungsten Advisors (buy-side) |
| Jul 2026 | PANTHERx Rare | Nautic Partners | Warburg Pincus-led investor group | Acquisition | Announced | – | Healthcare Services+2 | Centerview Partners (sell-side)Goldman Sachs (sell-side)Ropes & Gray (sell-side)J.P. Morgan (buy-side)Cleary Gottlieb Steen & Hamilton (buy-side) |
| Jul 2026 | newly established entity holding Bayer's long-acting reversible contraceptives (LARC) business | Bayer | Apollo | Stake | Announced | 3,465.9 | Pharma | Latham & Watkins (buy-side)Paul, Weiss (buy-side) |
| Jul 2026 | Small Door Veterinary | – | – | Merger | Announced | – | Pet+2 | Goodwin |
| Jul 2026 | Spire Healthcare portfolio of 12 acute-care hospitals | Spire Healthcare Group | Blue Owl Capital | Asset sale | Completed | – | Real Estate+1 | Kirkland & Ellis (buy-side)Rothschild & Co (buy-side)Hogan Lovells Cadwalader (buy-side)Deloitte (buy-side) |
| Jul 2026 | iRenix Medical | – | Tarsus Pharmaceuticals | Acquisition | Announced | 75.0 | Ophthalmology+2 | Piper Sandler (sell-side)DLA Piper (sell-side)Gunderson Dettmer (buy-side) |
| Jul 2026 | Corza Biosurgery | Corza Medical | EQT X | Asset sale | Pending | – | Medtech | Kirkland & Ellis (sell-side)Citi (sell-side)Moelis & Company (sell-side)Latham & Watkins (buy-side)Piper Sandler (buy-side) |
| Jul 2026 | Life Sciences & Healthcare segment | Clarivate | Altaris | Asset sale | Announced | 600.0 | Healthcare Software+2 | Davis Polk (sell-side)Morgan Stanley (sell-side)Hogan Lovells Cadwalader (sell-side)Joele Frank, Wilkinson Brimmer Katcher (sell-side)Kirkland & Ellis (buy-side) |
| Jul 2026 | XpresSpa Holdings | XWELL | Express Wellness Group | Acquisition | Announced | 13.0 | Consumer Services+2 | Roth Capital Partners (sell-side)Haynes Boone (sell-side)Dechert (buy-side) |
| Jul 2026 | DCM BioServices | – | Surplus Solutions | Acquisition | Announced | – | Life Sciences+1 | McDermott Will & Schulte (buy-side) |
| Jul 2026 | Crinetics Pharmaceuticals | – | Vertex Pharmaceuticals | Acquisition | Announced | 10,000.0 | Biotech+2 | Lazard (buy-side)J.P. Morgan (sell-side)Leerink Partners (sell-side)Paul, Weiss (sell-side)Morrison & Foerster (sell-side)Morgan Stanley (buy-side)Kirkland & Ellis (buy-side) |
| Jul 2026 | Lannett | – | Aurobindo | Acquisition | Completed | 250.0 | Pharma+1 | Raymond JamesSullivan & Cromwell (buy-side) |
| Jul 2026 | Helvoet Polymer Technologies | Hydratec Industries | Kimball Electronics | Acquisition | Completed | 104.4 | Contract Manufacturing+1 | MP Corporate Finance (sell-side)Roth Capital Partners (buy-side) |
| Jul 2026 | BridgeBio | – | Sixth Street | Stake | Completed | 1,000.0 | Biotech+1 | Sullivan & Cromwell (buy-side)Evercore (buy-side) |
| Jul 2026 | Kestrel | – | AbbVie | Acquisition | Announced | – | Biotech | Lazard |
| Jul 2026 | Healthpeak outpatient medical buildings joint venture | Healthpeak Properties | Brookfield Asset Management | Joint venture | Announced | 1,025.0 | Real Estate+1 | Kirkland & Ellis (buy-side) |
| Jul 2026 | LeadingReach | – | Enhanced Healthcare Partners | Stake | Announced | – | Healthcare Software | TripleTree |
| Jul 2026 | Exdion Healthcare Solutions | – | Experity | Acquisition | Completed | – | Healthcare Software+1 | TripleTreeLincoln International (sell-side) |
| Jul 2026 | Dreampath Diagnostics | – | Halma | Acquisition | Announced | – | Diagnostics+1 | Latham & Watkins (sell-side) |
| Jul 2026 | Unnamed Midwest provider of psychiatric medical care for elderly and disabled adults | – | Health Catalyst Capital | Acquisition | Completed | – | Healthcare Services+1 | |
| Jul 2026 | Healthpeak Properties | – | – | Joint venture | Announced | – | Real Estate+2 | Latham & Watkins |
| Jul 2026 | Stride Health | – | Integrity | Acquisition | Announced | – | Insurtech+1 | Kirkland & Ellis (buy-side) |
| Jul 2026 | Commissioning Agents | – | JLL Partners | Acquisition | Completed | – | Pharma Services+1 | Stout (sell-side) |
| Jul 2026 | OptiMed Health Partners | – | Lee Equity Partners | Stake | Completed | – | Pharma Services+1 | Edgemont Partners (sell-side) |
| Jul 2026 | MeiraGTx Holdings | – | Oberland Capital Management | Stake | Announced | – | Biotech+1 | Latham & Watkins (sell-side) |
| Jul 2026 | Momentum Life Sciences | – | Parthenon Capital Partners | Stake | Completed | – | Healthcare Software+1 | William Blair |
| Jul 2026 | Asembia | – | Peak Rock Capital | Acquisition | Completed | – | Pharma Services+2 | BofA Securities (sell-side)McDermott Will & Schulte (sell-side)Kirkland & Ellis (buy-side)Houlihan Lokey (buy-side)Bass, Berry & Sims (buy-side) |
| Jul 2026 | LaCorium Health | founders of LaCorium Health | Prestige Consumer Healthcare | Acquisition | Completed | – | Healthcare+1 | Addisons (sell-side)Pitcher Partners (buy-side) |
| Jul 2026 | Caring Transitions | – | Ridgemont Equity Partners | Acquisition | Completed | – | Consumer Services+2 | Livingstone Partners (sell-side)Keating Muething & Klekamp (sell-side)Boxwood Partners (buy-side)Alston & Bird (buy-side)Greenberg Traurig (buy-side) |
| Jul 2026 | B Medical Systems | Azenta | Thelema S.à r.l. | Asset sale | Completed | – | Medtech+1 | William Blair |
| Jul 2026 | Paradigm Oral Health | BlackRock Long Term Private Capital | Warburg Pincus | Acquisition | Completed | – | Healthcare Services | GoodwinLatham & Watkins (buy-side) |
| Jul 2026 | VitalRads | Thrive | Zoetis | Acquisition | Announced | – | Animal Health+1 | Guggenheim Securities (sell-side) |
| Jun 2026 | Pacira's iovera° business | Pacira BioSciences | Zimmer Biomet Holdings | Asset sale | Pending | 70.0 | Medtech | RBC Capital Markets (sell-side)Ashurst Perkins Coie (sell-side)Ice Miller (buy-side) |
| Jun 2026 | Kartos Therapeutics | – | Ipsen | Acquisition | Announced | 450.0 | Biotech+1 | Goldman Sachs (sell-side)PJT Partners (sell-side)DLA Piper (sell-side)Orrick (buy-side) |
| Jun 2026 | Talawar Therapeutics | – | JATT II Acquisition Corp | Merger | Announced | – | Biotech+1 | Cooley (sell-side)Greenberg Traurig (buy-side) |
| Jun 2026 | Theravance Biopharma | – | Zymeworks | Acquisition | Pending | 929.0 | Pharma+1 | Lazard (sell-side)Evercore (sell-side)Skadden, Arps, Slate, Meagher & Flom (sell-side)Arthur Cox (sell-side)Kirkland & Ellis (buy-side)Matheson (buy-side)MTS Health Partners (buy-side) |
| Jun 2026 | Advanced Medical Solutions Group | – | H.B. Fuller Company | Acquisition | Pending | 940.1 | Medtech+1 | Evercore (sell-side)Perella Weinberg Partners (buy-side)Goldman Sachs (buy-side)Ashurst Perkins Coie (buy-side) |
| Jun 2026 | Bio-Techne | – | Merck KGaA | Acquisition | Pending | 11,300.0 | Life Sciences+1 | Goldman Sachs (sell-side)Sidley Austin (sell-side)Joele Frank, Wilkinson Brimmer Katcher (sell-side)Guggenheim Securities (buy-side)J.P. Morgan (buy-side)Sullivan & Cromwell (buy-side) |
| Jun 2026 | Gentiva | Humana | – | Stake | Announced | 900.0 | Healthcare Services | Debevoise & PlimptonGuggenheim Securities (sell-side) |
| Jun 2026 | padoa | – | Thoma Bravo | Stake | Completed | – | Healthcare Software+1 | William BlairGoodwin (buy-side) |
Deals come from SEC filings (merger proxies, tender offers, 8-K announcements and IPO prospectuses), the deal pages and transaction lists of law firms and banks, companies' press releases and the press. How the data is built